Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

DarioHealth Q1 Sales $5.758M Miss $6.758M Estimate

Author: Benzinga Newsdesk | May 15, 2024 06:32am
DarioHealth (NASDAQ:DRIO) reported quarterly sales of $5.758 million which missed the analyst consensus estimate of $6.758 million by 14.80 percent. This is a 18.51 percent decrease over sales of $7.066 million the same period last year.

Posted In: DRIO

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist